Livalo

Hyperlipidemia, Hypercholesterolemia, Dyslipidemias

Treatment

5 FDA approvals

5 Active Studies for Livalo

What is Livalo

Pitavastatin

The Generic name of this drug

Treatment Summary

Pitavastatin, marketed under the name Livalo, is a type of cholesterol-lowering drug called a statin. Statins work by blocking an enzyme that helps the body produce cholesterol. This drug and other statins, such as atorvastatin, pravastatin, rosuvastatin, fluvastatin and lovastatin, are typically prescribed to people who are at risk of developing cardiovascular disease, such as those with type 2 diabetes. Pitavastatin has been proven to be effective in lowering LDL-C (bad cholesterol) and increasing HDL-C (good cholesterol), and is

Livalo

is the brand name

image of different drug pills on a surface

Livalo Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Livalo

Pitavastatin

2010

21

Approved as Treatment by the FDA

Pitavastatin, also called Livalo, is approved by the FDA for 5 uses including Heterozygous Familial Hypercholesterolemia (HeFH) and primary Hyperlipidemia .

Heterozygous Familial Hypercholesterolemia (HeFH)

primary Hyperlipidemia

Helps manage primary Hyperlipidemia

Hypercholesterolemia

Hyperlipidemia

Helps manage primary Hyperlipidemia

Dyslipidemias

Helps manage Mixed Dyslipidemias

Effectiveness

How Livalo Affects Patients

Pitavastatin is a medication that helps to lower cholesterol levels. It reduces total cholesterol, low-density lipoprotein-cholesterol (LDL-C), non-high density lipoprotein-cholesterol (non-HDL-C), apolipoprotein B (apoB) and triglycerides (TG) in the blood, while increasing levels of high-density lipoprotein-cholesterol (HDL-C). Having too much LDL-C, low HDL-C and high TG in the blood increases the risk of developing atherosclerosis and other cardiovascular diseases. Taking statins, like pitavast

How Livalo works in the body

Pitavastatin is a drug that helps reduce cholesterol levels. It does this by blocking the enzyme that turns a molecule called HMG-CoA into cholesterol. This creates less cholesterol in the liver, which causes the body to absorb more of it from the blood. Pitavastatin has been found to have additional benefits, such as improving blood vessel function, reducing inflammation and oxidative stress, and preventing the formation of blood clots. It also binds to a type of white blood cell, which helps reduce inflammation.

When to interrupt dosage

The suggested dosage of Livalo is established by the determined condition, such as Hyperlipidemia, Hypercholesterolemia and Dyslipidemias. The amount of dosage shifts, in line with the method of administration (e.g. Tablet, film coated - Oral or Tablet, film coated) as detailed in the following table.

Condition

Dosage

Administration

Hyperlipidemia

2.0 mg, 4.0 mg, , 1.0 mg, 2.09 mg, 1.045 mg, 4.18 mg

Tablet, film coated, Tablet, film coated - Oral, , Oral

Hypercholesterolemia

2.0 mg, 4.0 mg, , 1.0 mg, 2.09 mg, 1.045 mg, 4.18 mg

Tablet, film coated, Tablet, film coated - Oral, , Oral

Dyslipidemias

2.0 mg, 4.0 mg, , 1.0 mg, 2.09 mg, 1.045 mg, 4.18 mg

Tablet, film coated, Tablet, film coated - Oral, , Oral

Warnings

Livalo Contraindications

Condition

Risk Level

Notes

Breast Milk Production

Do Not Combine

Liver Diseases

Do Not Combine

Transaminases

Do Not Combine

Pulse Frequency

Do Not Combine

There are 20 known major drug interactions with Livalo.

Common Livalo Drug Interactions

Drug Name

Risk Level

Description

Brigatinib

Major

The metabolism of Brigatinib can be decreased when combined with Pitavastatin.

Cabazitaxel

Major

The metabolism of Cabazitaxel can be decreased when combined with Pitavastatin.

Enasidenib

Major

The metabolism of Enasidenib can be decreased when combined with Pitavastatin.

Fluorouracil

Major

The metabolism of Fluorouracil can be decreased when combined with Pitavastatin.

Fosphenytoin

Major

The metabolism of Fosphenytoin can be decreased when combined with Pitavastatin.

image of a doctor in a lab doing drug, clinical research

Livalo Novel Uses: Which Conditions Have a Clinical Trial Featuring Livalo?

Currently, 6 active clinical trials are exploring the potential of Livalo to ameliorate Dyslipidemias, Hyperlipidemia and Hypercholesterolemia.

Condition

Clinical Trials

Trial Phases

Hypercholesterolemia

4 Actively Recruiting

Phase 1, Phase 3

Hyperlipidemia

0 Actively Recruiting

Dyslipidemias

1 Actively Recruiting

Phase 2

Livalo Reviews: What are patients saying about Livalo?

5

Patient Review

12/17/2019

Livalo for Combined High Blood Cholesterol and Triglyceride Level

I had tried a variety of different statins before, and they all made me feel awful-- body aches, malaise, pain in my limbs. It was terrible. My PA finally convinced me to try LIVALO, and I'm so glad she did! I've been on it for over a year now with no problems whatsoever. Plus, my levels are "awesome" according to my PA.

4.3

Patient Review

9/4/2016

Livalo for High Cholesterol

I saw a significant decrease in my cholesterol levels, but have had some negative side effects like rashes, muscle cramps, and memory loss. I'm going to talk to my doctor about getting off of the medication.

3.7

Patient Review

3/24/2017

Livalo for High Cholesterol

The side effects I experienced from taking livalo were so bad that I had to stop. My doctor said that the benefits of this drug are not worth the pain and suffering it caused me. All I want is to feel normal again.

3

Patient Review

9/29/2018

Livalo for High Cholesterol

Livalo didn't give me the body aches that other statins did, but it did have some pretty severe anxiety and depression symptoms. I'm a 53 year old male, and these effects were really not worth it for me.

3

Patient Review

4/8/2022

Livalo for Combined High Blood Cholesterol and Triglyceride Level

I saw some good results in the short-term, but they weren't worth the intense leg pain and weakness I experienced. I would rather make a drastic change to my diet than deal with this medication long-term.

3

Patient Review

8/26/2017

Livalo for Combined High Blood Cholesterol and Triglyceride Level

I stopped taking this medication after only two months because I found that I had to urinate more frequently and my left kidney started hurting. Since I haven't gotten a blood test yet, it's hard to say how effective the drug actually was.

2.3

Patient Review

10/29/2021

Livalo for High Cholesterol

I have had a lot of negative side effects from taking statins in the past, including rashes, itching, and leg pain. Livalo has also made me feel very depressed and anxious, which is not how I usually feel. I am going to stop taking it and see if that makes a difference.

2.3

Patient Review

5/12/2016

Livalo for High Cholesterol

1.7

Patient Review

5/30/2018

Livalo for Combined High Blood Cholesterol and Triglyceride Level

After only taking Livalo for three weeks, I started experiencing a host of negative side effects. My hair has been falling out, my scalp and skin have been itching incessantly, and I've been having leg cramps. But the most concerning issue by far is that I've begun forgetting words and my speech has been slurring. I stopped taking the medication today.

1.7

Patient Review

7/13/2022

Livalo for Combined High Blood Cholesterol and Triglyceride Level

I was incredibly weak after taking this medication e.g. statin-induced myopathy. I felt like Livalo completely sucked the life and energy out of me, and it resulted in an ultra-depressive state. It's also super expensive, even with Medicare and Medigap Prescription Insurance coverage.

1.7

Patient Review

3/17/2021

Livalo for Combined High Blood Cholesterol and Triglyceride Level

I've been on this medication for two months now and I'm having serious negative mental health effects, like anxiety and anger. I also have physical pain in my calves as well as a ringing noise in my ear. To be honest, I'm scared to leave the house at this point.

1.7

Patient Review

7/15/2022

Livalo for Combined High Blood Cholesterol and Triglyceride Level

Being a type 2 diabetic, I was not on medication prior to taking cholesterol meds. However, when prescribed cholesterol meds (pravastatin and then livalo), my AC1 shot up to a 7.2 from a 6.6. As a result, I ended up having to take metformin. I experienced a brain fog that concerned me, as well as swelling in my feet and serious abdominal pain. After going off statins for 3 months, I brought my AC1 down immediately. Consequently, I will never take statins again.

1

Patient Review

12/28/2017

Livalo for High Cholesterol

I took Livalo for a month and a half, then stopped taking it. Ever since, my vision has been incredibly blurry to the point where I can't even drive anymore. Additionally, I've been having really severe cramping in my calves and hands. If it weren't for the fact that this medication has made my life absolutely miserable, I might be able to tolerate the cramping.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about livalo

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the side effects of Livalo?

"You may experience muscle pain, back pain, joint pain, pain in your arms and legs, diarrhea, constipation, skin rash, or headache."

Answered by AI

How does Livalo different from other statins?

"Livalo is a statin that reduces HMG-CoA. It is different from other statins because it has a cyclopropyl group on the base structure."

Answered by AI

What is the difference between Lipitor and Livalo?

"In a clinical trial comparing the effects of LIVALO and Lipitor in people with high cholesterol, it was shown that the 4-mg dose of LIVALO lowered LDL (bad) cholesterol just as much as Lipitor 20 mg, and that LIVALO 2 mg lowered it similarly to Lipitor 10 mg."

Answered by AI

What is special about Livalo?

"Livalo is a cholesterol-lowering medication for adults with high cholesterol. It helps to lower total cholesterol, "bad" cholesterol (LDL-C), triglycerides, and Apo B. It also raises "good" cholesterol (HDL-C)."

Answered by AI

Clinical Trials for Livalo

Image of Metabolic & Atherosclerosis Research Center in Cincinnati, United States.

Lerodalcibep for High Cholesterol

6 - 17
All Sexes
Cincinnati, OH

The goal of this clinical trial is to assess the LDL-Cholesterol reductions at Week 12 and Week 24 with monthly dosing of lerodalcibep (Lerochol) 300 mg administered subcutaneously by auto-injector (AI)/pre-filled pen (PFP) compared to placebo (dummy), in male and female pediatric patients 6 to 17 years of age, with inherited high cholesterol (HeFH) on a stable diet and maximally tolerated oral LDL C lowering drug therapy such as statins. The main question\[s\] it aims to answer are: How effective is Lerochol in reducing LDL cholesterol? How well is it tolerated and are there any safety concerns? Researchers will compare Lerochol to placebo (inert or dummy injection solution). Participants will visit the clinic every month for months and be asked to fast overnight, but allowed to drink water, before clinic visits. Undergo physical exams, height and weight measurements, answer questions, have blood drawn from a vein in their arm, have blood pressure measurements, EKC heart tests, and receive monthly injections lasting about 5 seconds in their arms or abdomen with an autoinjector.

Phase 3
Waitlist Available

Metabolic & Atherosclerosis Research Center

David Kallend, MB BS

LIB Therapeutics LLC

Image of Research Site in Chula Vista, United States.

AZD0780 for Hypercholesterolemia

18+
All Sexes
Chula Vista, CA

This is a study to evaluate the efficacy and safety of AZD0780 in adults with HeFH and elevated LDL-C, either with clinical ASCVD and LDL-C levels of 55 mg/dL or higher or without clinical ASCVD and LDL-C levels of 70 mg/dL or higher. AZD0780 is a small molecule that reduces the amount of LDL-C in the blood. Placebo will be used for comparison, and neither the participants nor the Investigators will know who is receiving the AZD0780 medication and who is receiving the placebo until the end of study. The total length of the study for an individual participant will be up to approximately 56 weeks, including a screening period of up to 14 days, treatment with AZD0780 or placebo for 52 weeks, and a safety follow-up period of 10 days.

Phase 3
Recruiting

Research Site (+28 Sites)

AstraZeneca

Have you considered Livalo clinical trials?

We made a collection of clinical trials featuring Livalo, we think they might fit your search criteria.
Go to Trials